MyMD Pharmaceuticals (MYMD) News Today

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

$2.51

-0.01 (-0.40%)

(As of 02:39 PM ET)

Source

Source	Headline
	Morning Bid: Dollar bulls enter the China shop msn.com - April 18 at 12:57 AM
	Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today? investorplace.com - April 9 at 8:21 AM
	Recursion Pharmaceuticals CEO sells over $1.16m in stock uk.investing.com - April 7 at 6:24 PM
	Exclusive-Software industry calls for more UK Government support msn.com - March 28 at 9:45 PM
	MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing finance.yahoo.com - March 5 at 10:56 AM
	MyMD Pharmaceuticals Stock (NASDAQ:MYMD), Short Interest Report benzinga.com - February 22 at 8:40 PM
	marketbeat.com - February 15 at 6:12 AM
	MyMD Pharmaceuticals down after announcing reverse stock split msn.com - February 13 at 3:56 PM
	MyMD Pharmaceuticals Inc Ordinary Shares morningstar.com - December 8 at 3:33 PM
	MyMD to begin Phase II trial of rheumatoid arthritis therapy msn.com - December 7 at 12:08 PM
	Five Hours Of Pain Relief? Preclinical Study Shows Promising Results With This Non-Toxic CBD benzinga.com - October 20 at 7:05 PM
	MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain finance.yahoo.com - October 19 at 2:05 PM
	Baltimore pharmaceutical company faces delisting from the Nasdaq bizjournals.com - October 18 at 11:53 PM
	FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA) finance.yahoo.com - August 14 at 6:17 PM
	MyMD Shares Surge on Positive Sarcopenia Study Results >MYMD marketwatch.com - July 31 at 12:26 PM
	MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty finance.yahoo.com - July 31 at 12:26 PM
	marketbeat.com - July 31 at 8:56 AM
	Will MyMD Pharmaceuticals (NASDAQ:MYMD) Spend Its Cash Wisely? finance.yahoo.com - May 17 at 9:09 AM
	MyMD Pharmaceuticals And Charles River Present Data For Next Generation, Oral TNF-α Inhibitor MYMD-1 In Rheumatoid Arthritis benzinga.com - March 22 at 3:06 PM
	MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis finance.yahoo.com - March 20 at 9:49 AM
	MyMD Joins LOT Network To Protect Company And Shareholders From Patent Trolls msn.com - March 8 at 12:52 PM
	MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical finance.yahoo.com - March 2 at 8:49 AM
	MyMD Pharmaceuticals® Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF-α Inhibitor MYMD-1® at the Society of Toxicology 2023 Annual Meeting finance.yahoo.com - February 28 at 11:33 AM
	MyMD Announces $15 Million Offering with Existing Investors finance.yahoo.com - February 21 at 9:11 AM
	ADDING MULTIMEDIA MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022 finance.yahoo.com - December 6 at 3:33 PM
	MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research finance.yahoo.com - November 14 at 8:36 AM
	Healthcare & Pharmaceuticals reuters.com - September 22 at 12:39 AM
	MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan finance.yahoo.com - September 20 at 5:49 PM
	MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD(TM) Compound stockhouse.com - August 31 at 9:20 PM
	Short Interest in MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) Grows By 24.8% marketbeat.com - August 30 at 12:35 PM
	MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound finance.yahoo.com - August 30 at 11:13 AM
	MyMD Pharmaceuticals, Inc. (MYMD) finance.yahoo.com - August 29 at 11:30 PM
	Data Showing MyMD Pharmaceuticals' MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences benzinga.com - August 5 at 7:57 PM
	Is MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) Popular Amongst Insiders? finance.yahoo.com - July 29 at 10:15 AM
	New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles \| DelveInsight finance.yahoo.com - July 26 at 1:28 PM
	MyMD Pharmaceuticals® Advances Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan finance.yahoo.com - July 26 at 8:28 AM
	MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions finance.yahoo.com - July 12 at 11:40 AM
	SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating MyMD Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors prnewswire.com - July 7 at 2:13 PM
	MyMD Pharmaceuticals Inc Ordinary Shares - Stock Chart morningstar.com - June 18 at 10:15 PM
	MyMD Pharmaceuticals Accelerates Pace of New Patient Dosing in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan finance.yahoo.com - April 5 at 1:14 PM
	MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan finance.yahoo.com - February 23 at 10:31 AM
	MyMD Pharma secures new U.S. patent covering MYMD-1 in a method of treating sarcopenia seekingalpha.com - January 5 at 12:58 PM
	MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia finance.yahoo.com - January 5 at 12:58 PM
	MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be Commercialized in Southeast Asia finance.yahoo.com - December 29 at 1:22 PM
	From Benzinga's Global Small Cap Conference: MyMD Pharmaceuticals, Chief Scientific Officer, Adam Kaplin PH.D. Begins Presenting benzinga.com - December 8 at 10:53 PM
	MyMD Pharmaceuticals Announces Issuance of U.S. Patent Covering Lead Drug Candidate MYMD-1 in a Method of Extending Lifespan finance.yahoo.com - November 23 at 9:39 AM
	MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America finance.yahoo.com - November 18 at 9:19 AM
	MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan finance.yahoo.com - November 16 at 11:16 AM
	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating MyMD Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors finance.yahoo.com - November 15 at 10:15 AM
	MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation finance.yahoo.com - October 26 at 11:52 AM

Get MyMD Pharmaceuticals News Delivered to You Automatically

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

MYMD Media Mentions By Week

MYMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MYMD
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

MYMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MYMD Articles
This Week
▼
1

0
▲
MYMD Articles
Average Week

Get MyMD Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:MYMD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MyMD Pharmaceuticals (MYMD) News Today

MYMD Media Mentions By Week

MYMD Media Sentiment

MYMD News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info